Aller au contenu
MediHelp
MediHelp Référence médicamenteuse

Interactions médicamenteuses

Cobimetinib + Netupitant-palonosetron

Gravité: Majeure

Cobimetinib and Netupitant-palonosetron: major interaction.

Dernière mise à jour

Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.

Le contenu clinique de cette page n'est disponible qu'en anglais.

Résumé

Netupitant inhibits CYP3A4 and can increase cobimetinib exposure. This may increase toxicities such as hemorrhage, rhabdomyolysis, retinopathy and liver injury.

Ce que signifie cette interaction, en termes simples

Cobimetinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Cobimetinib belongs to Oncology; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Niveau de preuve: Moderate

Pourquoi elle survient

CYP3A4 inhibition by netupitant reduces cobimetinib clearance.

Conduite à tenir

Prefer an antiemetic that does not inhibit CYP3A4. If short-term use is unavoidable, reduce cobimetinib to the labeled dose for moderate inhibitors and monitor for toxicity.

Questions à poser à votre pharmacien

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Réservé aux membres Pro+

Débloquer la page complète

Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Cobimetinib et Netupitant-palonosetron, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription
Créer un compte gratuit Se connecter

Essayez Pro+ gratuitement pendant 14 jours sur le web. Sans carte.

Questions fréquentes

Can I take Cobimetinib with Netupitant-palonosetron?

MediHelp rates the interaction as major. Cobimetinib and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Netupitant inhibits CYP3A4 and can increase cobimetinib exposure. This may increase toxicities such as hemorrhage, rhabdomyolysis, retinopathy and liver injury.

How serious is the interaction between Cobimetinib and Netupitant-palonosetron?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an antiemetic that does not inhibit CYP3A4. If short-term use is unavoidable, reduce cobimetinib to the labeled dose for moderate inhibitors and monitor for toxicity.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp

Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.

Télécharger surApp Store Disponible surGoogle Play

Parcourir de A à Z · Interactions médicamenteuses

Télécharger l'app Se connecter